For the aforementioned reasons, the synergy between MDM2 inhibitors combined with IR exposure may offer a more effective cancer treatment strategy, but more research is needed to reveal the exact mechanism of action and possible normal tissue toxicities (72). This evidence concerns the gene MDM2 and cancer.